{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:13:56Z","timestamp":1782285236628,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recently, the palliative appropriateness criteria (PAC) score, a\u00a0novel metric to aid clinical decision-making between different palliative radiotherapy fractionation regimens, has been developed. It includes baseline parameters including but not limited to performance status. The researchers behind the PAC score analyzed the percent of remaining life (PRL) on treatment. The latter was accomplished by calculating the time between start and finish of palliative radiotherapy (minimum 1\u00a0day in case of a\u00a0single-fraction regimen) and dividing it by overall survival in days from start of radiotherapy. The purpose of the present study was to validate this novel metric.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>The retrospective validation study included 219\u00a0patients (287 courses of palliative radiotherapy). The methods were identical to those employed in the score development study. The score was calculated by assigning 1\u00a0point each to several factors identified in the original study and using the online calculator provided by the PAC developers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median survival was 6\u00a0months and death within 30\u00a0days from start of radiotherapy was recorded in 13% of courses. PRL on treatment ranged from 1 to 23%, median\u00a08%. Significant associations were confirmed between online-calculated PAC score, observed survival, and risk of death within 30\u00a0days from the start of radiotherapy. Patients with score\u00a00 had distinctly better survival than all other groups. The score-predicted median risk of death within 30\u00a0days from start of radiotherapy was 22% in our cohort. A statistically significant correlation was found between predicted and observed risk (<jats:italic>p<\/jats:italic>\u202f&lt;\u20090.001). The original and present study were not perfectly concordant regarding number and type of baseline parameters that should be included when calculating the PAC score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study supports the dual strategy of PRL and risk of early death calculation, with results stratified for fractionation regimen, in line with the original PAC score study. When considering multifraction regimens, the PAC score identifies patients who may benefit from shorter courses. Additional work is needed to answer open questions surrounding the underlying components of the score, because the original and validation study were only partially aligned.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00066-022-02040-y","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T09:04:06Z","timestamp":1673341446000},"page":"278-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Palliative appropriateness criteria: external validation of a\u00a0new method to evaluate the suitability of palliative radiotherapy fractionation"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1592-2908","authenticated-orcid":false,"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellinor C.","family":"Haukland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e5rd","family":"Manns\u00e5ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Dalhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"2040_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.soc.2021.02.007","volume":"30","author":"GR Williams","year":"2021","unstructured":"Williams\u00a0GR, Manjunath\u00a0SH, Butala\u00a0AA, Jones\u00a0JA (2021) Palliative radiotherapy for advanced cancers: indications and outcomes. Surg Oncol Clin N Am 30:563\u2013580","journal-title":"Surg Oncol Clin N Am"},{"key":"2040_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijrobp.2015.09.045","volume":"94","author":"WJ Mackillop","year":"2016","unstructured":"Mackillop\u00a0WJ, Kong\u00a0W (2016) Estimating the need for palliative radiation therapy: a benchmarking approach. Int J Radiat Oncol Biol Phys 94:51\u201359","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2040_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00066-021-01760-x","volume":"197","author":"T Saito","year":"2021","unstructured":"Saito\u00a0T, Murotani\u00a0K, Yamaguchi\u00a0K, Toya\u00a0R, Tomitaka\u00a0E, Watakabe\u00a0T, Oya\u00a0N (2021) Influence of pain duration on pain outcomes following palliative radiotherapy for painful tumors: the sooner the irradiation, the better? Strahlenther Onkol 197:916\u2013925","journal-title":"Strahlenther Onkol"},{"key":"2040_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2018.03.018","volume":"126","author":"C Nieder","year":"2018","unstructured":"Nieder\u00a0C, Mehta\u00a0MP, Geinitz\u00a0H, Grosu\u00a0AL (2018) Prognostic and predictive factors in patients with brain metastases from solid tumors: a review of published nomograms. Crit Rev Oncol Hematol 126:13\u201318","journal-title":"Crit Rev Oncol Hematol"},{"key":"2040_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00066-013-0507-y","volume":"190","author":"B van Oorschot","year":"2014","unstructured":"van Oorschot\u00a0B, Assenbrunner\u00a0B, Schuler\u00a0M, Beckmann\u00a0G, Flentje\u00a0M (2014) Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer. Strahlenther Onkol 190:270\u2013275","journal-title":"Strahlenther Onkol"},{"key":"2040_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002143.pub4","author":"R Stevens","year":"2015","unstructured":"Stevens\u00a0R, Macbeth\u00a0F, Toy\u00a0E, Coles\u00a0B, Lester\u00a0JF (2015) Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002143.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2040_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.prro.2022.03.012","volume":"12","author":"D Rades","year":"2022","unstructured":"Rades\u00a0D, Cacicedo\u00a0J, Lomidze\u00a0D, Al-Salool\u00a0A, Segedin\u00a0B, Groselj\u00a0B, Jankarashvili\u00a0N, Conde-Moreno\u00a0AJ, Schild\u00a0SE (2022) A new and easy-to-use survival score for patients irradiated for metastatic epidural spinal cord compression. Pract Radiat Oncol 12:354\u2013362","journal-title":"Pract Radiat Oncol"},{"key":"2040_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12904-019-0415-8","volume":"18","author":"SY Wu","year":"2019","unstructured":"Wu\u00a0SY, Singer\u00a0L, Boreta\u00a0L, Garcia\u00a0MA, Fogh\u00a0SE, Braunstein\u00a0SE (2019) Palliative radiotherapy near the end of life. BMC Palliat Care 18:29. https:\/\/doi.org\/10.1186\/s12904-019-0415-8","journal-title":"BMC Palliat Care"},{"key":"2040_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.radonc.2017.09.016","volume":"125","author":"KR Park","year":"2017","unstructured":"Park\u00a0KR, Lee\u00a0CG, Tseng\u00a0YD, Liao\u00a0JJ, Reddy\u00a0S, Bruera\u00a0E, Yennurajalingam\u00a0S (2017) Palliative radiation therapy in the last 30 days of life: a systematic review. Radiother Oncol 125:193\u2013199. https:\/\/doi.org\/10.1016\/j.radonc.2017.09.016","journal-title":"Radiother Oncol"},{"key":"2040_CR10","doi-asserted-by":"publisher","first-page":"e2115641","DOI":"10.1001\/jamanetworkopen.2021.15641","volume":"4","author":"SY Wu","year":"2021","unstructured":"Wu\u00a0SY, Yee\u00a0E, Vasudevan\u00a0HN, Fogh\u00a0SE, Boreta\u00a0L, Braunstein\u00a0SE, Hong\u00a0JC (2021) Risk stratification for imminent risk of death at the time of palliative radiotherapy consultation. JAMA Netw Open 4:e2115641. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.15641","journal-title":"JAMA Netw Open"},{"key":"2040_CR11","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1038\/s41598-020-62826-x","volume":"10","author":"SF Lee","year":"2020","unstructured":"Lee\u00a0SF, Luk\u00a0H, Wong\u00a0A, Ng\u00a0CK, Wong\u00a0FCS, Luque-Fernandez\u00a0MA (2020) Prediction model for short-term mortality after palliative radiotherapy for patients having advanced cancer: a cohort study from routine electronic medical data. Sci Rep 10:5779. https:\/\/doi.org\/10.1038\/s41598-020-62826-x","journal-title":"Sci Rep"},{"key":"2040_CR12","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2022.0173","author":"JC Farris","year":"2022","unstructured":"Farris\u00a0JC, Johnson\u00a0AG, Carriere\u00a0PP, Patel\u00a0ZA, Nagatsuka\u00a0M, Farris\u00a0MK, Hughes\u00a0RT (2022) Palliative appropriateness criteria: a pragmatic method to evaluate the suitability of palliative radiotherapy fractionation. J\u00a0Palliat Med. https:\/\/doi.org\/10.1089\/jpm.2022.0173","journal-title":"J Palliat Med"},{"key":"2040_CR13","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1016\/j.cllc.2017.01.006","volume":"18","author":"C Nieder","year":"2017","unstructured":"Nieder\u00a0C, Toll\u00e5li\u00a0T, Haukland\u00a0E, Reigstad\u00a0A, Flat\u00f8y\u00a0LR, Dalhaug\u00a0A (2017) External validation of a prognostic score for patients receiving palliative thoracic radiotherapy for lung cancer. Clin Lung Cancer 18:e297\u2013e301. https:\/\/doi.org\/10.1016\/j.cllc.2017.01.006","journal-title":"Clin Lung Cancer"},{"key":"2040_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000506954","volume":"43","author":"C Nieder","year":"2020","unstructured":"Nieder\u00a0C, Hess\u00a0S, Lewitzki\u00a0V (2020) External validation of a prognostic score for patients with brain metastases: Extended diagnosis-specific graded prognostic assessment. Oncol Res Treat 43:221\u2013227","journal-title":"Oncol Res Treat"},{"key":"2040_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ijrobp.2020.05.023","volume":"108","author":"SR Alcorn","year":"2020","unstructured":"Alcorn\u00a0SR, Fiksel\u00a0J, Wright\u00a0JL, Elledge\u00a0CR, Smith\u00a0TJ, Perng\u00a0P, Saleemi\u00a0S, McNutt\u00a0TR, DeWeese\u00a0TL, Zeger\u00a0S (2020) Developing an improved statistical approach for survival estimation in bone metastases management: the Bone Metastases Ensemble Trees for Survival (BMETS) model. Int J Radiat Oncol Biol Phys 108:554\u2013563. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.05.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2040_CR16","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto\u00a0PW, Mesko\u00a0S, Li\u00a0J, Cagney\u00a0D, Aizer\u00a0A, Lin\u00a0NU, Nesbit\u00a0E, Kruser\u00a0TJ, Chan\u00a0J, Braunstein\u00a0S, Lee\u00a0J, Kirkpatrick\u00a0JP, Breen\u00a0W, Brown\u00a0PD, Shi\u00a0D, Shih\u00a0HA, Soliman\u00a0H, Sahgal\u00a0A, Shanley\u00a0R, Sperduto\u00a0WA, Lou\u00a0E, Everett\u00a0A, Boggs\u00a0DH, Masucci\u00a0L, Roberge\u00a0D, Remick\u00a0J, Plichta\u00a0K, Buatti\u00a0JM, Jain\u00a0S, Gaspar\u00a0LE, Wu\u00a0CC, Wang\u00a0TJC, Bryant\u00a0J, Chuong\u00a0M, An\u00a0Y, Chiang\u00a0V, Nakano\u00a0T, Aoyama\u00a0H, Mehta\u00a0MP (2020) Survival in patients with brain metastases: Summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J\u00a0Clin Oncol 38:3773\u20133784","journal-title":"J Clin Oncol"},{"key":"2040_CR17","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1200\/JCO.2008.17.1363","volume":"26","author":"E Chow","year":"2008","unstructured":"Chow\u00a0E, Abdolell\u00a0M, Panzarella\u00a0T, Harris\u00a0K, Bezjak\u00a0A, Warde\u00a0P, Tannock\u00a0I (2008) Predictive model for survival in patients with advanced cancer. J\u00a0Clin Oncol 26:5863\u20135869. https:\/\/doi.org\/10.1200\/JCO.2008.17.1363","journal-title":"J Clin Oncol"},{"key":"2040_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/cncr.28408","volume":"120","author":"MS Krishnan","year":"2014","unstructured":"Krishnan\u00a0MS, Epstein-Peterson\u00a0Z, Chen\u00a0YH, Tseng\u00a0YD, Wright\u00a0AA, Temel\u00a0JS, Catalano\u00a0P, Balboni\u00a0TA (2014) Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: the TEACHH model. Cancer 120:134\u2013141. https:\/\/doi.org\/10.1002\/cncr.28408","journal-title":"Cancer"},{"key":"2040_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/1754-9485.13185","volume":"65","author":"I Pobar","year":"2021","unstructured":"Pobar\u00a0I, Job\u00a0M, Holt\u00a0T, Hargrave\u00a0C, Hickey\u00a0B (2021) Prognostic tools for survival prediction in advanced cancer patients: a systematic review. J\u00a0Med Imaging Radiat Oncol 65:806\u2013816. https:\/\/doi.org\/10.1111\/1754-9485.13185","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2040_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ijrobp.2008.03.019","volume":"73","author":"E Chow","year":"2009","unstructured":"Chow\u00a0E, Abdolell\u00a0M, Panzarella\u00a0T, Harris\u00a0K, Bezjak\u00a0A, Warde\u00a0P, Tannock\u00a0I (2009) Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 73:280\u2013287. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2040_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3171\/2013.9.JNS13788","volume":"120","author":"D Kondziolka","year":"2014","unstructured":"Kondziolka\u00a0D, Parry\u00a0PV, Lunsford\u00a0LD, Kano\u00a0H, Flickinger\u00a0JC, Rakfal\u00a0S, Arai\u00a0Y, Loeffler\u00a0JS, Rush\u00a0S, Knisely\u00a0JP, Sheehan\u00a0J, Friedman\u00a0W, Tarhini\u00a0AA, Francis\u00a0L, Lieberman\u00a0F, Ahluwalia\u00a0MS, Linskey\u00a0ME, McDermott\u00a0M, Sperduto\u00a0P, Stupp\u00a0R (2014) The accuracy of predicting survival in individual patients with cancer. J\u00a0Neurosurg 120:24\u201330. https:\/\/doi.org\/10.3171\/2013.9.JNS13788","journal-title":"J Neurosurg"},{"key":"2040_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00066-013-0471-6","volume":"190","author":"B Berger","year":"2014","unstructured":"Berger\u00a0B, Ankele\u00a0H, Bamberg\u00a0M, Zips\u00a0D (2014) Patients who die during palliative radiotherapy. Status survey. Strahlenther Onkol 190:217\u2013220","journal-title":"Strahlenther Onkol"},{"key":"2040_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-022-01993-4","author":"M Moll","year":"2022","unstructured":"Moll\u00a0M, Herrmann\u00a0H, Zaharie\u00a0A, Goldner\u00a0G (2022) Clinical outcome in metastatic prostate cancer after primary radiotherapy. Strahlenther Onkol. https:\/\/doi.org\/10.1007\/s00066-022-01993-4","journal-title":"Strahlenther Onkol"},{"key":"2040_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00066-022-02003-3","volume":"198","author":"KH Kahl","year":"2022","unstructured":"Kahl\u00a0KH, Shiban\u00a0E, Gutser\u00a0S, Maurer\u00a0CJ, Sommer\u00a0B, M\u00fcller\u00a0H, Konietzko\u00a0I, Grossert\u00a0U, Berlis\u00a0A, Janzen\u00a0T, St\u00fcben\u00a0G (2022) Focal cavity radiotherapy after neurosurgical resection of brain metastases: sparing neurotoxicity without compromising locoregional control. Strahlenther Onkol 198:1105\u20131111. https:\/\/doi.org\/10.1007\/s00066-022-02003-3","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-022-02040-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T18:39:45Z","timestamp":1676659185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-022-02040-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s00066-022-02040-y","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.\u00a0Nieder, E.C.\u00a0Haukland, B.\u00a0Manns\u00e5ker, and A.\u00a0Dalhaug declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. This research project was carried out according to our institutions\u2019 guidelines and with permission to access the patients\u2019 data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}